PRNewsWire · November 4, 2026

ImmunoGenesis to Present IND-Enabling Development Progress and Therapeutic Potential of IMGS-203, a Novel STING Agonist, at SITC 2026 Annual Meeting

Get the app for more

Explore stock news, insights and company research.